Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial
Not yet recruitingOBSERVATIONAL
Enrollment
29
Participants
Timeline
Start Date
February 28, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Conditions
Small Cell Lung Cancer Extensive StageELDERLY PEOPLE
All Listed Sponsors
lead
Nanjing First Hospital, Nanjing Medical University